MEMBRANE PERMEATION MECHANISMS OF 2'-DIDEOXYNUCLEOSIDES,3'-DIDEOXYNUCLEOSIDES

被引:31
作者
DOMIN, BA
MAHONY, WB
ZIMMERMAN, TP
机构
[1] Division of Experimental Therapy, Wellcome Research Laboratories, Research Triangle Park
关键词
D O I
10.1016/0006-2952(93)90560-J
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The mechanism of membrane permeation of several 2',3'-dideoxynucleosides was investigated at 37-degrees with human erythrocyles using an ''inhibitor-stop'' assay. Transport (per 5 muL cells) via the nucleoside and nucleobase carriers was assessed by inhibition of influx with dilazep and adenine, respectively. Mechanisms of cellular entry were highly individualized: 2',3'-dideoxyadenosine and 3'-deoxythymidin-2'-ene via nonfacilitated diffusion, with high rates; 2',3'-dideoxyguanosine mainly via the nucleobase carrier (K(m) = 390 muM, V(max) = 32 pmol/sec); 2',3'-dideoxyinosine by both nucleobase (K(m) = 850 muM, V(max) = 2.7 pmol/sec) and nucleoside (K(m) = 7.4 mM, V(max) = 16 pmol/sec) carriers, with a low rate of nonfacilitated diffusion; and 2',3'-dideoxycytidine, equally by the nuclcoside carrier (K(m) = 23 mM, V(max) = 65 pmol/sec) and by nonfacilitated diffusion, with a low rate. These results demonstrate that the nucleobase carrier plays an important role in the influx of two of these dideoxynucleosides and that nonfacilitated diffusion is not necessarily the chief mode of membrane permeation of this class of drugs.
引用
收藏
页码:725 / 729
页数:5
相关论文
共 24 条
[1]   UPTAKE OF 2',3'-DIDEOXYADENOSINE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED AND NONINFECTED HUMAN-CELLS [J].
AGARWAL, RP ;
BUSSO, ME ;
MIAN, AM ;
RESNICK, L .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1989, 5 (05) :541-550
[2]   INITIAL STUDIES ON THE CELLULAR PHARMACOLOGY OF 2',3'-DIDEOXYINOSINE, AN INHIBITOR OF HIV INFECTIVITY [J].
AHLUWALIA, G ;
COONEY, DA ;
MITSUYA, H ;
FRIDLAND, A ;
FLORA, KP ;
HAO, Z ;
DALAL, M ;
BRODER, S ;
JOHNS, DG .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (22) :3797-3800
[3]  
AU JLS, 1989, CLIN CHEM, V35, P48
[4]  
AUGUST EM, 1991, MOL PHARMACOL, V39, P246
[5]   CELLULAR PHARMACOLOGY AND ANTI-HIV ACTIVITY OF 2',3'-DIDEOXYGUANOSINE [J].
BUSSO, ME ;
RESNICK, L ;
YANG, BH ;
MIAN, AM .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (09) :1139-1146
[6]   INITIAL STUDIES ON THE CELLULAR PHARMACOLOGY OF 2',3'-DIDEOXYCYTIDINE, AN INHIBITOR OF HTLV-III INFECTIVITY [J].
COONEY, DA ;
DALAL, M ;
MITSUYA, H ;
MCMAHON, JB ;
NADKARNI, M ;
BALZARINI, J ;
BRODER, S ;
JOHNS, DG .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (13) :2065-2068
[7]   2',3'-DIDEOXYTHYMIDINE PERMEATION OF THE HUMAN-ERYTHROCYTE MEMBRANE BY NONFACILITATED DIFFUSION [J].
DOMIN, BA ;
MAHONY, WB ;
ZIMMERMAN, TP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 154 (03) :825-831
[8]  
DOMIN BA, 1988, J BIOL CHEM, V263, P9276
[9]  
DOMIN BA, 1992, MOL PHARMACOL, V41, P950
[10]   STRUCTURAL MODIFICATIONS AT THE 2'-POSITION AND 3'-POSITION OF SOME PYRIMIDINE NUCLEOSIDES AS DETERMINANTS OF THEIR INTERACTION WITH THE MOUSE ERYTHROCYTE NUCLEOSIDE TRANSPORTER [J].
GATI, WP ;
MISRA, HK ;
KNAUS, EE ;
WIEBE, LI .
BIOCHEMICAL PHARMACOLOGY, 1984, 33 (21) :3325-3331